文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

调控毒力控制病原体与肠道微生物群落竞争的能力。

Regulated virulence controls the ability of a pathogen to compete with the gut microbiota.

机构信息

Department of Pathology and Comprehensive Cancer Center, The University of Michigan Medical School, Ann Arbor, MI 48109, USA.

出版信息

Science. 2012 Jun 8;336(6086):1325-9. doi: 10.1126/science.1222195. Epub 2012 May 10.


DOI:10.1126/science.1222195
PMID:22582016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3439148/
Abstract

The virulence mechanisms that allow pathogens to colonize the intestine remain unclear. Here, we show that germ-free animals are unable to eradicate Citrobacter rodentium, a model for human infections with attaching and effacing bacteria. Early in infection, virulence genes were expressed and required for pathogen growth in conventionally raised mice but not germ-free mice. Virulence gene expression was down-regulated during the late phase of infection, which led to relocation of the pathogen to the intestinal lumen where it was outcompeted by commensals. The ability of commensals to outcompete C. rodentium was determined, at least in part, by the capacity of the pathogen and commensals to grow on structurally similar carbohydrates. Thus, pathogen colonization is controlled by bacterial virulence and through competition with metabolically related commensals.

摘要

定植机制使得病原体能够在肠道中定植的机制仍不清楚。在这里,我们表明无菌动物无法根除鼠柠檬酸杆菌,柠檬酸杆菌是一种用于模拟人类附着和消除细菌感染的模型。在感染早期,毒力基因被表达,并需要在常规饲养的小鼠中生长,但在无菌小鼠中不需要。在感染后期,毒力基因的表达下调,导致病原体转移到肠道腔中,在那里它被共生菌所竞争。共生菌竞争柠檬酸杆菌的能力至少部分取决于病原体和共生菌在结构相似的碳水化合物上生长的能力。因此,病原体定植受到细菌毒力和与代谢相关的共生菌竞争的控制。

相似文献

[1]
Regulated virulence controls the ability of a pathogen to compete with the gut microbiota.

Science. 2012-5-10

[2]
Microbiology. Virulence or competition?

Science. 2012-6-8

[3]
Linking Pathogen Virulence, Host Immunity and The Microbiota at the Intestinal Barrier.

Keio J Med. 2017

[4]
Citrobacter amalonaticus Inhibits the Growth of Citrobacter rodentium in the Gut Lumen.

mBio. 2021-10-26

[5]
Humoral Immunity in the Gut Selectively Targets Phenotypically Virulent Attaching-and-Effacing Bacteria for Intraluminal Elimination.

Cell Host Microbe. 2015-5-13

[6]
RegA, an AraC-like protein, is a global transcriptional regulator that controls virulence gene expression in Citrobacter rodentium.

Infect Immun. 2008-11

[7]
Bacterial Adrenergic Sensors Regulate Virulence of Enteric Pathogens in the Gut.

mBio. 2016-6-7

[8]
Intimate Adhesion Is Essential for the Pathogen-Specific Inflammatory and Immune Responses in the Gut of Mice Infected with .

Immunohorizons. 2021-10-26

[9]
Indole Signaling at the Host-Microbiota-Pathogen Interface.

mBio. 2019-6-4

[10]
Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells.

Mucosal Immunol. 2016-9-14

引用本文的文献

[1]
Convergent evolution of distinct D-ribulose utilisation pathways in attaching and effacing pathogens.

Nat Commun. 2025-7-29

[2]
Non-antibiotics disrupt colonization resistance against enteropathogens.

Nature. 2025-7-16

[3]
Gut microbiota dysbiosis in inflammatory bowel disease: interaction with intestinal barriers and microbiota-targeted treatment options.

Front Cell Infect Microbiol. 2025-6-27

[4]
The accessory type III secretion system effectors collectively shape intestinal inflammatory infection outcomes.

Gut Microbes. 2025-12

[5]
The Role of -Sorbose Metabolism in Enhancing Fitness and Virulence in Under Acidic Conditions.

Infect Drug Resist. 2025-6-20

[6]
Lactobacillus plantarum-derived extracellular vesicles from dietary barley leaf supplementation attenuate Citrobacter rodentium infection and intestinal inflammation.

J Nanobiotechnology. 2025-6-7

[7]
The gut microbiome: an emerging epicenter of antimicrobial resistance?

Front Microbiol. 2025-5-20

[8]
Defining enteric bacterial pathogenesis using organoids: uses EspC, an atypical mucinolytic protease, to penetrate mouse colonic mucus.

Gut Microbes. 2025-12

[9]
Harnessing the human gut microbiota: an emerging frontier in combatting multidrug-resistant bacteria.

Front Immunol. 2025-3-17

[10]
Inducible transposon mutagenesis identifies bacterial fitness determinants during infection in mice.

Nat Microbiol. 2025-5

本文引用的文献

[1]
Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease.

Cell Host Microbe. 2011-5-19

[2]
Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.

PLoS Pathog. 2010-5-13

[3]
A human gut microbial gene catalogue established by metagenomic sequencing.

Nature. 2010-3-4

[4]
Induction of intestinal Th17 cells by segmented filamentous bacteria.

Cell. 2009-10-30

[5]
Community-wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep sequencing.

Infect Immun. 2009-10

[6]
Utility of the Citrobacter rodentium infection model in laboratory mice.

Curr Opin Gastroenterol. 2008-1

[7]
Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae.

Cell Host Microbe. 2007-9-13

[8]
Citrobacter rodentium of mice and man.

Cell Microbiol. 2005-12

[9]
A positive regulatory loop controls expression of the locus of enterocyte effacement-encoded regulators Ler and GrlA.

J Bacteriol. 2005-12

[10]
Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies.

Infect Immun. 2004-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索